Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HCC × Ethiodized Oil × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Hepatocellular 18 Liver Neoplasms 3 Recurrence 2 Uveal Melanoma 1 Sarcoma 1 Recurrence Hepatocellular Carcinoma 1 Pleural Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoplastic Cells, Circulating 1 Neoplasm Recurrence, Local 1 Mediastinal Neoplasms 1 Malignant Neoplasm in the Head and Neck 1 Lung Neoplasms 1 Lung Metastases 1 Liver Cirrhosis 1 HCC 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

nimotuzumab 1 atezolizumab 1 Stents 1 Sorafenib 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Ethiodized Oil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03108248 2017-04-11

ISP-TACE Versus TACE for HCC With PVTT

Zhongda Hospital

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡